Presentation is loading. Please wait.

Presentation is loading. Please wait.

Analysis of absolute CD4+ cytokine+ cell numbers pre- and post-ART.

Published byBenny Lesmono Modified over 5 years ago

Similar presentations

Presentation on theme: "Analysis of absolute CD4+ cytokine+ cell numbers pre- and post-ART."— Presentation transcript:

1 Analysis of absolute CD4+ cytokine+ cell numbers pre- and post-ART.
Analysis of absolute CD4+ cytokine+ cell numbers pre- and post-ART. PBMCs from patients prior to and at 12 mo of ART were simulated with EC, PPD, HIV, or anti-CD3/CD28 overnight and analyzed for absolute levels of CD4+IFN-γ+, IL-2+, TNF-α+, or total cytokine-positive cells. A–D, Absolute number of cytokine positive cells after anti-CD3/CD28 (A), HIV-1 (B), EC (C), or PPD (D) stimulation. Bar indicates median of 16 patients (pre-ART, filled circles; post-ART, open circles). Data were analyzed using a Wilcoxon matched t test and p values are indicated. Jayne S. Sutherland et al. J Immunol 2010;184: Copyright © 2010 by The American Association of Immunologists, Inc.

Download ppt "Analysis of absolute CD4+ cytokine+ cell numbers pre- and post-ART."

Similar presentations

V43 DNA-Ad26-ALVAC Study ELISpot SFC/Million PBMC.

V43 DNA-Ad26-ALVAC Study ELISpot SFC/Million PBMC.
Fig. 3. IL-4, IFN-γ, and IL-17 production from α-GalCer-stimulated iNKT cells following FlaB treatment of PBMC cultures from asthma patients and healthy.

Fig. 3. IL-4, IFN-γ, and IL-17 production from α-GalCer-stimulated iNKT cells following FlaB treatment of PBMC cultures from asthma patients and healthy.
Figure 6. The effect of GV1001 on ENO1-induced pro-inflammatory cytokine production in RA PBMCs. RA PBMCs were pre-treated with GV1001 (100 µM) for 1 h.

Figure 6. The effect of GV1001 on ENO1-induced pro-inflammatory cytokine production in RA PBMCs. RA PBMCs were pre-treated with GV1001 (100 µM) for 1 h.
Volume 108, Pages (January 2018)

Volume 108, Pages (January 2018)
NK cells inhibited the expansion and function of ILC2s in vitro via IFN-γ. NK cells inhibited the expansion and function of ILC2s in vitro via IFN-γ. ILC2s.

NK cells inhibited the expansion and function of ILC2s in vitro via IFN-γ. NK cells inhibited the expansion and function of ILC2s in vitro via IFN-γ. ILC2s.
Activation of NK cells during the early stage of allergic and fibrotic lung inflammation. Activation of NK cells during the early stage of allergic and.

Activation of NK cells during the early stage of allergic and fibrotic lung inflammation. Activation of NK cells during the early stage of allergic and.
Enhanced ILC2 expansion after depletion of NK cells during the early stage of allergic and fibrotic lung inflammation. Enhanced ILC2 expansion after depletion.

Enhanced ILC2 expansion after depletion of NK cells during the early stage of allergic and fibrotic lung inflammation. Enhanced ILC2 expansion after depletion.
Dominant IL-21 expression in TFH cells correlate with B cell pathology in HIV-infected LNs. Dominant IL-21 expression in TFH cells correlate with B cell.

Dominant IL-21 expression in TFH cells correlate with B cell pathology in HIV-infected LNs. Dominant IL-21 expression in TFH cells correlate with B cell.
Synergistic antitumor effect of anti-CD40/CpG and 14

Synergistic antitumor effect of anti-CD40/CpG and 14
Antitumor effect of the combination of IL-2 IC and anti–CTLA-4.

Antitumor effect of the combination of IL-2 IC and anti–CTLA-4.
Rab11-FIP3 silencing impairs T cell activation events.

Rab11-FIP3 silencing impairs T cell activation events.
Anti-CD40 and CpG induce activation of T cells in draining lymph nodes

Anti-CD40 and CpG induce activation of T cells in draining lymph nodes
Immunologic effects of F16-IL2 therapy.

Immunologic effects of F16-IL2 therapy.
Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome by Yolanda.

Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1–infected patients with immune reconstitution inflammatory syndrome by Yolanda.
Figure 2 Systemic immune responses to cryptococcal antigen

Figure 2 Systemic immune responses to cryptococcal antigen
Interleukin (IL)-1β-producing cells in peripheral blood mononuclear cells (PBMCs). Interleukin (IL)-1β-producing cells in peripheral blood mononuclear.

Interleukin (IL)-1β-producing cells in peripheral blood mononuclear cells (PBMCs). Interleukin (IL)-1β-producing cells in peripheral blood mononuclear.
Cytokine and chemokine expression of flucloxacillin-specific T cell clones (TCC) of patient P1. Cytokine and chemokine expression of flucloxacillin-specific.

Cytokine and chemokine expression of flucloxacillin-specific T cell clones (TCC) of patient P1. Cytokine and chemokine expression of flucloxacillin-specific.
FIG. S4. IL-8 IL-10 IL-12 IL-6 TNF IFN-γ

FIG. S4. IL-8 IL-10 IL-12 IL-6 TNF IFN-γ
Volume 21, Issue 4, Pages e4 (April 2017)

Volume 21, Issue 4, Pages e4 (April 2017)
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.

Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.

Similar presentations

Ads by Google